http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16906633

Outgoing Links

Predicate Object
contentType Journal Article|Published Erratum
issn 2156-6976
issueIdentifier 9
pageRange 1899-
publicationName American journal of cancer research
startingPage 1899
bibliographicCitation Tang X, Yang L, Li Z, Nalin AP, Dai H, Xu T, Yin J, You F, Zhu M, Shen W, Chen G, Zhu X, Wu D, Yu J. Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia. Am J Cancer Res. 2018;8(9):1899. PMID: 30323981; PMCID: PMC6176185.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a063901e9a5340ea04bd7d48d58fa9e4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f749cfdca0d90dd1b6d4e4932dc98ecc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_34dec25afff7e0a6a1bc2df40af7fbcd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9ccc1dfe906350704c895d4d0876b786
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_522c31741d20601dcf2a1e5a23d9681b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6889890b5f4956b54dc6f6cc717d17af
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9c9963fdb9639373e26e6cae3762c59
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f7a269c7da40ca429682d099f729c83d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16e75832cc69a51e801f9adc07c885ce
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed38994c28473fa316beda9b8e329401
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_96cd295850345de164fd6cf8f4ae2488
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b636647f440db9041e42e18e4365d7b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3dece6a21ea411d4b474215112c1644f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab01ae9bd45a7acdc853e9a0b0641450
date 2018
identifier https://pubmed.ncbi.nlm.nih.gov/PMC6176185
https://pubmed.ncbi.nlm.nih.gov/30323981
isPartOf https://portal.issn.org/resource/ISSN/2156-6976
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/38854
language English
source https://pubmed.ncbi.nlm.nih.gov/
title Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7cae9972de6deccb83ee4f720cac0e7d
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9731

Total number of triples: 31.